A Tiny Enzyme Flaw May Explain How Dementia Begins
Scientists have identified a small flaw in the enzyme GPX4 that prevents neurons from defending themselves. This mutation, found in children with a rare form of early dementia, disrupts a tiny loop ...
Framework can improve Alzheimer's treatment efficacy by tracking anti-Aβ therapy response
In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These monoclonal anti-Aβs are proteins made ...
A Natural Molecule Shows Surprising Power Against Alzheimer’s
Scientists have uncovered how a molecule called spermine, naturally produced by the body, helps cells neutralize toxic protein buildups linked to Alzheimer’s and Parkinson’s. By encouraging these ...
New Research Links Shingles Vaccine To Reduced Dementia Risk
But new research suggests that a vaccine designed to protect you from shingles may have an unexpected hidden perk: It could ...
Morning Overview on MSN
GLP-1 drugs fail to slow Alzheimer’s in 2 major trials
Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that ...
Fighting Dementia Could Be as Easy as the Shingles Vaccine
A relatively mundane middle-aged rite of passage — shingles vaccination — might offer an added benefit: protection against, ...
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at the Clinica…
Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate ...
New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced ...
The New York Times
A Different Type of Dementia Is Changing What’s Known About Cognitive Decline
On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, scientists say. Doctors told Ray Hester he was in the beginning stages of ...
CBS News
AI can already do the work of 12% of America's workforce, MIT researchers find
Artificial intelligence can do the work currently performed by nearly 12% of America's workforce, according to a recent study from the Massachusetts Institute of Technology. The researchers, relying ...
USA Today
Ozempic pill failed to slow Alzheimer's. But could it reveal new clues?
Novo Nordisk won't add Alzheimer's disease to the list of conditions its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, can treat, despite high hopes and two years of study. The ...
Phys.org
Researchers find smaller amounts of microplastics in southern Narragansett Bay
It's safe to say Rhode Islanders have a symbiotic relationship with Narragansett Bay. Its status as New England's tidal estuary helps define Rhode Island as the Ocean State. For hundreds of years, ...